Dankert-Roelse J E, te Meerman G J
Department of Paediatrics, Paediatric Pulmonology, University of Groningen, The Netherlands.
Thorax. 1995 Jul;50(7):712-8. doi: 10.1136/thx.50.7.712.
A study was undertaken to evaluate whether an early diagnosis by neonatal screening may improve the long term prognosis of patients with cystic fibrosis and to assess the influence of expert management started immediately after the diagnosis.
Comparative clinical follow up in three birth cohorts of patients with cystic fibrosis was performed at the Cystic Fibrosis centre in Groningen in close collaboration with paediatricians in general hospitals in the north-eastern part of the Netherlands. The first birth cohort (n = 19) was detected by screening and the two other cohorts were detected clinically, one (n = 30) consisting of patients born during the screening programme and the other (n = 32) of patients born during the six years immediately after the screening programme ended. The total number of patients in the three birth cohorts included all patients with cystic fibrosis born in this area during a 12 year period. Cumulative survival rates and the variation with time of lung function, the levels of immunoglobulins, and growth patterns were used as main outcome measures.
Patients born during the screening programme but detected clinically appeared to have a reduced life expectancy compared with patients detected by screening. The patients detected by screening showed less deterioration in lung function (annual decrease 1.2% of FEV1 % pred), a smaller increase in immunoglobulin levels, and minimal catch-up growth compared with an annual decrease of 3.25% of FEV1 % pred in the non-screened birth cohort of the same age, a higher rise in immunoglobulins leading to increased levels at the end of the observation period, and catch-up growth for weight as well as height. Differences between patients treated in a cystic fibrosis centre and those not referred to a specialist centre were smaller but similar, in favour of treatment at a cystic fibrosis clinic.
Expert management started immediately after an early diagnosis of cystic fibrosis by neonatal screening results in important beneficial effects on the outcome and clinical course of the condition. The institution of very early treatment may be critical for the outcome and long term prognosis for most patients with cystic fibrosis. Neonatal screening programmes for cystic fibrosis should be introduced more widely.
开展了一项研究,以评估新生儿筛查早期诊断是否可改善囊性纤维化患者的长期预后,并评估诊断后立即开始的专家管理的影响。
在格罗宁根的囊性纤维化中心与荷兰东北部综合医院的儿科医生密切合作,对三个囊性纤维化患者出生队列进行了比较临床随访。第一个出生队列(n = 19)通过筛查发现,另外两个队列通过临床诊断,一个队列(n = 30)由筛查计划期间出生的患者组成,另一个队列(n = 32)由筛查计划结束后的六年内出生的患者组成。三个出生队列中的患者总数包括该地区12年内出生的所有囊性纤维化患者。累积生存率以及肺功能随时间的变化、免疫球蛋白水平和生长模式用作主要结局指标。
筛查计划期间出生但通过临床诊断的患者与通过筛查发现的患者相比,预期寿命似乎缩短。与同年龄未筛查出生队列中FEV1%预计值每年下降3.25%相比,通过筛查发现的患者肺功能恶化程度较小(FEV1%预计值每年下降1.2%),免疫球蛋白水平升高幅度较小,追赶生长最小;免疫球蛋白升高幅度更大,导致观察期末水平升高,体重和身高均有追赶生长。在囊性纤维化中心接受治疗的患者与未转诊至专科中心的患者之间的差异较小但相似,支持在囊性纤维化诊所进行治疗。
通过新生儿筛查早期诊断囊性纤维化后立即开始的专家管理对该疾病的结局和临床病程产生重要有益影响。对于大多数囊性纤维化患者来说,极早期治疗的实施可能对结局和长期预后至关重要。应更广泛地开展囊性纤维化新生儿筛查计划。